Janus Living, Inc.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Scott M. Brinker
- Full Time Employees
- 5
- Sector
- Finance
- Industry
- Real estate investment trusts
- Address
- 4600 South Syracuse Street Denver CO United States 80237
- IPO Date
- Mar 20, 2026
- CIK
- 0002100805
- Website
- janusreit.com
- Similar Companies
- Business
- JanOne Inc. (Nasdaq: JAN) operates as a clinical-stage biopharmaceutical company focused on developing non-opioid, non-addictive therapies for severe pain and addiction, alongside appliance recycling services; its Biotechnology segment advances product candidates including JAN101, a patented oral sustained-release sodium nitrite formulation targeting peripheral artery disease and diabetic neuropathy pain by improving blood flow to extremities, and JAN123, a low-dose naltrexone formulation for complex regional pain syndrome that received U.S. patent approval and FDA orphan drug designation; the Recycling segment, through subsidiary ARCA Recycling, provides turnkey appliance recycling and replacement services for utilities sponsoring energy efficiency programs in North America. The company serves healthcare providers, patients with chronic pain conditions, and utility sponsors, with operations spanning the United States and global fintech expansion potential via recent initiatives. Founded in 1976 and headquartered in Las Vegas, Nevada, JanOne Inc. was formerly Appliance Recycling Centers of America, Inc., changing its name in September 2019 to reflect its pivot toward pain treatment innovation. In May 2024, JanOne completed the acquisition of ALT 5 Sigma Inc., a blockchain financial technology provider offering ALT5 Pay cryptocurrency payment gateway and ALT5 Prime over-the-counter trading platform with over $1.1 billion in 2023 transactional volume, prompting a strategic realignment to enhance stockholder value by potentially separating biotech and fintech operations; the company also confirmed a name change to Alt5 Sigma Corporation with new ticker ALTS in July 2024, appointed Vay Tham as Chief Revenue Officer and ALT5 President in June 2024, and integrated prepaid Visa card functionality into the ALT5 Settlement Platform.
Company News
JAN (NYSE:JAN) Receives Average Rating of “Moderate Buy” from Brokerages
Janus Living Announces Dates of Third Quarter 2026 Earnings Release, Conference Call, and Webcast
Janus Living Announces Closing of Upsized $1.25 Billion Revolving Credit Facility
Janus Living Declares Monthly Common Stock Cash Dividends for the Fourth Quarter of 2026
JAN’s Lock-Up Period Will End on September 16th (NYSE:JAN)
Janus Living: How $29 Is Worth More Than $29
JAN (NYSE:JAN) Sees Large Volume Increase on Analyst Upgrade
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock
Janus Living Announces Launch of Public Offering of Class A-1 Common Stock
JAN Q2 Earnings Call Highlights
Janus Living, Inc. (JAN) Q2 2026 Earnings Call Transcript
Janus Living Reports Second Quarter 2026 Results and Increases Full Year 2026 Guidance
5 Monthly Dividend Stocks Paying Up To 18.2%
Potential Earnings Are Not Reflected In REIT Multiples
Janus Living Declares Monthly Common Stock Cash Dividends for the Third Quarter of 2026
Janus Living: The Pure Play On Senior Housing Growth
Janus Living: After Recent IPO, Senior-Care REIT Goes On Property Shopping Spree
Janus Living Announces Dates of Second Quarter 2026 Earnings Release, Conference Call, and Webcast
Janus Living Announces Pricing of Public Offering of Class A-1 Common Stock